一、董事会召开情况 苏州珂玛材料科技股份有限公司（以下简称"公司"）第三届董事会第八次会议 （以下简称"会议"）于 2025 年 10 月 29 日在江苏省苏州市虎丘区漓江路 58 号 6#厂 房东以现场结合通讯方式举行，会议通知于 2025 年 10 月 24 日通过邮件方式发出。 会议应出席董事 7 人，实际出席董事 7 人（其中董事胡文、范春仙、RONG YIMING、 徐冬梅以通讯表决方式审议表决），公司高级管理人员列席了会议。本次会议的召开 符合相关法律法规和《公司章程》的规定。 本次会议由董事长刘先兵召集并主持，会议审议并以现场及在线记名投票表决 的方式通过各项议案，会议一致形成如下决议。 证券代码：301611 证券简称：珂玛科技 公告编号：2025-058 苏州珂玛材料科技股份有限公司 第三届董事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 表决结果：同意的 7 票；反对的 0 票；弃权的 0 票。 该事项在公司董事会审批权限内，无需提交股东大会审议。 三、备查文件 1、苏州珂玛材料科技股份有限公司第三届董事会第八次会议 ...

Core Insights - The company reported a third-quarter revenue of 274 million yuan, representing a year-on-year increase of 18.10% [1] - The net profit for the third quarter was 72.66 million yuan, showing a decline of 16.16% [1] - For the first three quarters, the total revenue reached 794 million yuan, with a year-on-year growth of 28.86% [1] - The net profit for the first three quarters was 245 million yuan, reflecting a year-on-year increase of 8.29% [1]

Financial Performance - The company's revenue for Q3 2025 reached ¥273,541,457.02, representing an increase of 18.10% year-on-year, while the revenue for the year-to-date period was ¥793,939,041.42, up 28.86% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2025 was ¥72,656,425.02, a decrease of 16.16% year-on-year, with year-to-date net profit at ¥244,520,318.40, an increase of 8.29%[5]. - The company's basic earnings per share for Q3 2025 was ¥0.17, down 26.09% year-on-year, while the diluted earnings per share remained the same[5]. - Total operating revenue for the period reached RMB 793,939,041.42, an increase of 28.8% compared to RMB 616,143,829.77 in the previous period[23]. - Net profit attributable to shareholders of the parent company was RMB 244,520,318.40, up from RMB 225,801,117.08, reflecting a growth of 8.0%[23]. Assets and Liabilities - Total assets as of the end of Q3 2025 were ¥2,475,442,897.55, reflecting a 25.83% increase from the end of the previous year[5]. - Total assets increased to RMB 2,475,442,897.55 from RMB 1,967,300,323.94, representing a growth of 25.8%[22]. - Total liabilities rose to RMB 736,343,504.34, compared to RMB 447,890,505.13, marking an increase of 64.5%[22]. Cash Flow - The net cash flow from investing activities for the first nine months of 2025 was -¥223,254,826.74, primarily due to the acquisition expenses related to Suzhou Kaixin[12]. - Operating cash inflow for the current period reached RMB 716,563,737.40, an increase of 21.4% compared to RMB 590,084,083.82 in the previous period[24]. - Net cash flow from operating activities was RMB 182,510,223.45, up from RMB 158,837,352.67, reflecting a growth of 14.9%[24]. - Cash outflow from investment activities totaled RMB 392,375,218.14, significantly higher than RMB 195,675,923.68 in the previous period, resulting in a net cash outflow of RMB 223,254,826.74[24]. - Cash inflow from financing activities was RMB 146,024,206.10, down from RMB 695,005,431.00, leading to a net cash inflow of RMB 68,034,923.75[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,606[14]. - Liu Xianbing holds 44.19% of shares, totaling 192,649,465 shares[14]. - Hu Wen holds 16.67% of shares, totaling 72,676,450 shares[14]. - The top ten shareholders include Suzhou Boying Enterprise Management Consulting Center with 3.65% (15,925,314 shares) and Beijing Novartis Capital Investment Management with 1.92% (8,369,575 shares)[14]. - The company has a total of 8,369,575 unrestricted shares held by Beijing Novartis Capital Investment Management[14]. Research and Development - Research and development expenses for the first nine months of 2025 amounted to ¥73,978,942.53, a 46.83% increase compared to the same period in 2024, indicating a continued commitment to R&D investment[11]. - Research and development expenses increased to RMB 73,978,942.53 from RMB 50,383,250.52, reflecting a rise of 46.8%[23]. Governance and Compliance - The company held board meetings on August 22, 2025, and September 10, 2025, to approve key governance changes, including the cancellation of the supervisory board[18]. - The company will elect employee representatives to the board, with terms lasting until the end of the current board's tenure[18]. - The company has made adjustments to its articles of association to comply with new legal and regulatory requirements[18]. - The company is committed to transparency and has published relevant announcements regarding governance changes on its information platform[18]. Strategic Initiatives - The company has a strategic plan to expand its market presence, focusing on new product development and technology advancements[1]. - The company is actively engaging in mergers and acquisitions to enhance its competitive position in the market[1]. Accounting and Audit - The company did not conduct an audit for the third quarter financial report[25]. - The new accounting standards will be implemented starting in 2025, affecting the financial statements[25].

Core Points - Kema Technology announced on October 30 that it received a notification from the Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified objects [2] - The application documents submitted by the company were deemed complete by the Shenzhen Stock Exchange, which decided to accept the application [2] - The issuance of convertible bonds is subject to further review by the Shenzhen Stock Exchange and requires approval from the China Securities Regulatory Commission, introducing uncertainty regarding the final approval and timeline [2]

Core Points - Company received notification from Shenzhen Stock Exchange regarding the acceptance of its application for issuing convertible bonds to unspecified objects [1] - The application documents submitted by the company were found to be complete and have been accepted for review by the exchange [1] - The issuance of convertible bonds is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission [1]

Core Viewpoint - Kema Technology (301611.SZ) has received acceptance from the Shenzhen Stock Exchange for its application to issue convertible bonds to unspecified objects, indicating a positive step towards raising capital [1] Group 1 - The company submitted its application for issuing convertible bonds on October 29, 2025 [1] - The Shenzhen Stock Exchange confirmed that the application documents were complete and decided to accept the application [1]

上海市通力律师事务所 关于苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券之 法律意见书 致：苏州珂玛材料科技股份有限公司 敬启者： 上海市通力律师事务所（以下简称"本所"）根据《中华人民共和国证券法》《中 华人民共和国公司法》《上市公司证券发行注册管理办法》和有权立法机构、监管机构 已公开颁布、生效且现时有效的法律、法规以及规范性文件等有关规定（以下简称"法 律、法规以及规范性文件"），按照律师行业公认的业务标准、道德规范和勤勉尽责精 神，出具本法律意见书。 （引 言） 根据苏州珂玛材料科技股份有限公司（以下简称"珂玛科技"或"发行人"）的委 托，本所指派张征轶律师、韩政律师、马宇曈律师（以下合称"本所律师"）作为发行 人向不特定对象发行可转换公司债券（以下简称"本次发行"）的专项法律顾问，就本 法律意见书出具日前已经发生的事实或存在的事实，根据本所律师对法律、法规以及规 范性文件的理解出具法律意见。 25SH3490005/WM/kw/cm/D1 4-1-1 一. 律师事务所与本所律师 (一) 律师事务所简介 本所系经上海市司法局批准，于 1998 年 9 月成立的合伙制律师事务 所，注册于上 ...

股票简称：珂玛科技 股票代码：301611 苏州珂玛材料科技股份有限公司 Suzhou Kematek, Inc. （苏州市高新区新钱路 1 号） 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 二零二五年十月 苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券募集说明书 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对申请文件及 所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、投 资价值或者对投资者的收益作出实质性判断或保证。任何与之相反的声明均属虚假不实 陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发行人自 行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自行承担证券依法发 行后因发行人经营与收益变化或者证券价格变动引致的投资风险。 向不特定对象发行可转换公司债券 募集说明书 任何投资者一经通过认购、交易、受让、继承或者其他合法方式持有本次债券，即 视作同意《受托管理协议》《债券持有人会议规则》及本募集说明书中其他有关发行人、 债券持有人、债券受托管理人等主体权利义务的相关约定， ...

中信证券股份有限公司 关于 苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券 之 上市保荐书 保荐人（主承销商） 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 二〇二五年十月 | 声 | 明 | 2 | | --- | --- | --- | | 第一节 | 本次证券发行基本情况 3 | | | 第二节 | 保荐人承诺事项 | 27 | | 第三节 | 保荐人对本次证券发行上市的保荐结论 29 | | | 第四节 | 对公司持续督导期间的工作安排 30 | | 苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券之上市保荐书 声 明 中信证券股份有限公司（以下简称"中信证券"、"保荐人"或"保荐机构"）接 受苏州珂玛材料科技股份有限公司（以下简称"珂玛科技"、"发行人"或"公司"） 的委托，担任其向不特定对象发行可转换公司债券的保荐人。 中信证券股份有限公司及保荐代表人根据《公司法》《证券法》等有关法律、法规、 中国证监会及深圳证券交易所的有关规定，诚实守信，勤勉尽责，严格按照依法制订的 业务规则、行业执业规范和道德准则出具上市保荐书，并保证所出具文件的真实性、准 确性、完整 ...

中信证券股份有限公司 关于 苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券 之 发行保荐书 保荐人（主承销商） 广东省深圳市福田区中心三路8号卓越时代广场（二期）北座 二〇二五年十月 苏州珂玛材料科技股份有限公司 向不特定对象发行可转换公司债券之发行保荐书 声 明 本保荐人及保荐代表人根据《公司法》《证券法》《上市公司证券发行注 册管理办法》《深圳证券交易所创业板股票上市规则》《证券发行上市保荐业 务管理办法》《深圳证券交易所上市公司证券发行与承销业务实施细则》等有 关法律、行政法规和中国证券监督管理委员会、深圳证券交易所的规定，诚实 守信，勤勉尽责，严格按照依法制订的业务规则和行业自律规范出具发行保荐 书，并保证所出具文件真实、准确、完整。 如无特别说明，本发行保荐书中的简称与《苏州珂玛材料科技股份有限公 司向不特定对象发行可转换公司债券募集说明书》中简称具有相同含义。 3-1-1 | 目 | 录 | 2 | | --- | --- | --- | | 第一节 | 本次证券发行基本情况 | 3 | | 第二节 | | | | | 保荐人承诺事项 | 8 | | 第三节 | 对本次证券发行的推荐 ...